• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,755.05 -715.06
( -0.92%)
Global Indices
Nasdaq
52,245.67 385.41
(0.74%)
Dow Jones
7,529.66 65.38
(0.88%)
Hang Seng
66,164.55 -67.64
(-0.10%)
Nikkei 225
10,722.03 136.12
(1.29%)
Forex
USD-INR
96.43 0.01
(0.01%)
EUR-INR
110.17 -0.09
(-0.08%)
GBP-INR
129.67 0.03
(0.02%)
JPY-INR
0.59 0.00
(0.01%)

EQUITY - MARKET SCREENER

Lyka Labs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500259
INE933A01014
24.1923243
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LYKALABS
0
238.86
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 
( Cr)
ParticularsMar 2026 ( Cr)Dec 2025 ( Cr)Sep 2025 ( Cr)
Gross Sales28.0330.7332.97
Other Operating Income0.000.000.00
Other Income 0.511.371.21
Total Income28.5432.0934.19
Total Expenditure 55.5328.8336.12
PBIDT-26.993.26-1.94
Interest 0.870.820.79
PBDT-27.862.45-2.73
Depreciation2.042.152.07
Tax0.340.000.18
Fringe Benefit Tax0.000.000.00
Deferred Tax-0.470.00-1.35
Reported Profit After Tax-29.770.29-3.63
Extra-ordinary Items -22.750.000.00
Adjusted Profit After Extra-ordinary item-7.020.29-3.63
EPS (Unit Curr.)-8.340.08-1.02
EPS (Adj) (Unit Curr.)-8.340.08-1.02
Calculated EPS (Unit Curr.)-8.340.08-1.02
Calculated EPS (Adj) (Unit Curr.)-8.340.08-1.02
Calculated EPS (Ann.) (Unit Curr.)-33.370.33-4.06
Calculated EPS (Adj) (Ann.) (Unit Curr.)-33.370.33-4.06
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity35.6935.6935.69
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)-96.2910.61-5.88
PBDTM(%)-99.397.97-8.28
PATM(%)-106.210.94-11.01